Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Oldham

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variantsRitah Nabunje, Beatriz Guillen-Guio, Tamara Hernandez-Beeftink, et al.
The European Respiratory Journal|May 5, 2018
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysisAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary FibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.
The Lancet. Respiratory Medicine|January 22, 2022
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysisWillis S Bowman, Chad A Newton, Angela L Linderholm, et al.
Chest|October 16, 2023
A Deep Learning-Based Radiomic Classifier for Usual Interstitial PneumoniaJonathan H Chung, Lydia Chelala, Janelle Vu Pugashetti, et al.
The European Respiratory Journal|July 18, 2020
Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotypeJulia Graham, Iazsmin Bauer Ventura, Chad A Newton, et al.
BMC Pulmonary Medicine|December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2024
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosisJanelle Vu Pugashetti, John S Kim, Michael P Combs, et al.
The European Respiratory Journal|November 5, 2021
Lung function trajectory in progressive fibrosing interstitial lung diseaseJustin M Oldham, Cathryn T Lee, Zhe Wu, et al.
JAMA Network Open|March 10, 2023
Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US AdultsAyodeji Adegunsoye, Elizabeth Freiheit, Emily N White, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variantsRitah Nabunje, Beatriz Guillen-Guio, Tamara Hernandez-Beeftink, et al.
The European Respiratory Journal|May 5, 2018
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysisAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary FibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.
The Lancet. Respiratory Medicine|January 22, 2022
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysisWillis S Bowman, Chad A Newton, Angela L Linderholm, et al.
Chest|October 16, 2023
A Deep Learning-Based Radiomic Classifier for Usual Interstitial PneumoniaJonathan H Chung, Lydia Chelala, Janelle Vu Pugashetti, et al.
The European Respiratory Journal|July 18, 2020
Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotypeJulia Graham, Iazsmin Bauer Ventura, Chad A Newton, et al.
BMC Pulmonary Medicine|December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2024
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosisJanelle Vu Pugashetti, John S Kim, Michael P Combs, et al.
The European Respiratory Journal|November 5, 2021
Lung function trajectory in progressive fibrosing interstitial lung diseaseJustin M Oldham, Cathryn T Lee, Zhe Wu, et al.
JAMA Network Open|March 10, 2023
Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US AdultsAyodeji Adegunsoye, Elizabeth Freiheit, Emily N White, et al.
Pageof 17